| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105524 Cysteine protease inhibitors |
| 05/05/2011 | US20110105523 Bifeprunox derivatives |
| 05/05/2011 | US20110105522 Ketoconazole-derivative antagonist of human pregnane x receptor and uses thereof |
| 05/05/2011 | US20110105521 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathway |
| 05/05/2011 | US20110105515 Targeting the oncoprotein nucleophosmin |
| 05/05/2011 | US20110105512 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105501 Pharmaceutical combinations |
| 05/05/2011 | US20110105500 Pyrazine substituted purines |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105497 Compounds and methods for treatment of cancer |
| 05/05/2011 | US20110105490 2,3-dihydro-1h-isoindol-1-imine derivatives useful as thrombin par-1 receptor antagonist |
| 05/05/2011 | US20110105482 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders |
| 05/05/2011 | US20110105476 Substituted 7,8-dihydro-1hpyrimido[4,5-b]diazepin-4-amines are novel kinase inhibitors |
| 05/05/2011 | US20110105474 Heterocyclic derivatives as hdac inhibitors |
| 05/05/2011 | US20110105470 Novel Lapachone Compounds And Methods of Use Thereof |
| 05/05/2011 | US20110105464 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105457 Heterocyclic compound having inhibitory activity on pi3k |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105445 Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105437 Mitochondrially Delivered Anti-Cancer Compounds |
| 05/05/2011 | US20110105436 Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| 05/05/2011 | US20110105431 Boronic Acid Aryl Analogs |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105425 Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer |
| 05/05/2011 | US20110105422 Use of g-rich oligonucleotides for treating neoplastic diseases |
| 05/05/2011 | US20110105419 Pharmacological adjuvants based on coordination compounds of d-metals |
| 05/05/2011 | US20110105413 Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
| 05/05/2011 | US20110105409 Anticancer Compounds |
| 05/05/2011 | US20110105408 Therapeutic peptides |
| 05/05/2011 | US20110105407 Tissue Inhibitor of Metalloproteinases (Timp) Linked to Glycosylphosphatidylinositol (Gpi) - Anchors for Treatment of Cancer and Skin Lesions |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105395 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 05/05/2011 | US20110105387 Method of treatment with rapamycin |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104306 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers |
| 05/05/2011 | US20110104305 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 05/05/2011 | US20110104304 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104294 Magnetic nanocomposite for inhibiting/treating cancer and method for fabricating the same |
| 05/05/2011 | US20110104293 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 05/05/2011 | US20110104287 Fenoldopam formulations and pro-drug derivatives |
| 05/05/2011 | US20110104286 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 05/05/2011 | US20110104268 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104258 Technique for drug and gene delivery to the cell cytosol |
| 05/05/2011 | US20110104256 Methods for treating or preventing colorectal cancer |
| 05/05/2011 | US20110104254 Medicament for treatment of tumors wherein hedgehog/smoothened signaling is employed for inhibition of apoptosis of the tumor cells |
| 05/05/2011 | US20110104252 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 05/05/2011 | US20110104249 Oncotherapeutic Application of Inhibitors of High-Affinity Glucose Transporters |
| 05/05/2011 | US20110104248 Liposomes and immunopotentiating compositions containing the same |
| 05/05/2011 | US20110104210 Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104200 Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines |
| 05/05/2011 | US20110104188 Novel glycolipid and use thereof |
| 05/05/2011 | US20110104186 Small molecule immunopotentiators and assays for their detection |
| 05/05/2011 | US20110104183 Use of sip1 as determinant of breast cancer stemness |
| 05/05/2011 | US20110104177 Histone deacetylase inhibitors, combination therapies and methods of use |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104166 Methods and Compositions for Treating Polyps |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | US20110104161 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer |
| 05/05/2011 | US20110104160 Medicament for treating cancer |
| 05/05/2011 | US20110104158 Deuterium bearing analogs of anastrozole as aromatase inhibitors for the treatment of breast cancer |
| 05/05/2011 | US20110104157 Liver cancer drug |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104148 Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof |
| 05/05/2011 | US20110104147 Identification of Tumor-Associated Markers for Diagnosis and Therapy |
| 05/05/2011 | US20110104143 Treating Basal-Like Genotype Cancers |
| 05/05/2011 | US20110104139 ANGIOSTATIC COMPOSITIONS COMPRISING TRUNCATED TYROSYL-tRNA SYNTHETASE POLYPEPTIDES AND METHODS OF USING SAME |
| 05/05/2011 | US20110104136 Natural Killer p30 (NKp30) Dysfunction and the Biological Applications Thereof |
| 05/05/2011 | US20110104132 Fgf-9 and its use relating to blood vessels |
| 05/05/2011 | US20110104130 Thymidylate kinase fusions and uses thereof |
| 05/05/2011 | US20110104129 T cell receptors and related materials and methods of use |
| 05/05/2011 | US20110104119 Chimeric Vectors |
| 05/05/2011 | US20110104118 Compositions and methods for therapeutic use |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104112 Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | US20110104101 Immunotherapy for Unresectable Pancreatic Cancer |
| 05/05/2011 | US20110104073 Iron/Iron Oxide Nanoparticle and Use Thereof |
| 05/05/2011 | US20110104065 Genetic alteration associated with pre-malignant cancer |
| 05/05/2011 | US20110104062 Biomarkers for Head-And-Neck Cancers and Precancers |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104058 Dimeric molecular complexes |
| 05/05/2011 | US20110104057 Novel [F-18]-labelled L-glutamic acid and L-glutamine derivatives (II), their use and processes for their preparation |
| 05/05/2011 | US20110104054 Small-Molecule HSP90 Inhibitors |
| 05/05/2011 | US20110104052 Methods of synthesis and use of chemospheres |
| 05/05/2011 | US20110104051 Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | US20110104049 Method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection |